SELECT-2 clinical trial assessing the efficacy and saftey of controlled- release interferon alpha-2B (CR2b)+ribavirin (RBV) versus pegylated interferon alpha-2B (Peg2b)+RBV in treatment-NaïVE genotype-1 (G1) hepatitis C

Category Primary study
JournalGastroenterology
Year 2011
This article has no abstract
Epistemonikos ID: 9bd9c69563a66809056fcbb66fd168268c9f97e1
First added on: Feb 04, 2025